Results 161 to 170 of about 13,559 (225)

Topical Medroxyprogesterone Acetate and Corneal Epithelium Healing after Photorefractive Keratectomy: A Randomized, Double-masked Contralateral Eye Study. [PDF]

J Res Pharm Pract
Peyman A, Pourazizi M, Irajpour M, Noorshargh P, Aslani A.   +4 more
europepmc   +1 more source

Effect of medroxyprogesterone acetate dose in progestin-primed ovarian stimulation on pregnancy outcomes in poor ovarian response patients with different body mass index levels. [PDF]

Front Endocrinol (Lausanne)
Zhang Q, He S, Meng Y, Yin T, Ming L, Yang J, Li S.   +6 more
europepmc   +1 more source

Medroxyprogesterone acetate in the management of cancer cachexia

Expert Opinion on Pharmacotherapy, 2009
Medroxyprogesterone acetate (MPA) is a synthetic, orally active derivative of the natural steroid hormone progesterone, widely used in oncology both in the endocrine treatment of hormone-related cancers and as supportive therapy in the cachexia syndrome.The anticachectic mechanisms of medroxyprogesterone, beyond its endocrine activity, are described to
Clélia Madeddu, Antonio Maccio, Filomena Panzone   +2 more
exaly   +5 more sources

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial

Contraception, 2016
ObjectiveTo describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM-PrEP HIV prevention trial, and to compare MPA levels between ARV for HIV prevention (treatment) and placebo groups.Study ...
Rebecca L Callahan, Kawango Ågot, David Jenkins   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

IMMUNOSUPPRESSION WITH MEDROXYPROGESTERONE ACETATE

Transplantation, 1968
The immunosuppressive effects of MPA (medroxyprogesterone acetate) were tested in clinical studies with laboratory dogs and rabbits. The laboratory procedures employed in the studies are explained and results are tabulated and graphed. 2 microscopic photographs illustrate the observed effects.
J G, Turcotte, R F, Haines, G L, Brody, T J, Meyer, S A, Schwartz   +4 more
openaire   +2 more sources

Medroxyprogesterone acetate therapy in hirsutism

British Journal of Dermatology, 1985
In a pilot study, 26 hirsute females were treated with medroxyprogesterone acetate (MPA). We used an ointment containing 0.2% MPA in 13 patients, subcutaneous injection of MPA into the hairy areas of the face in five patients and intramuscular injection of low doses of MPA in 13 patients, each for an average duration of 16 weeks.
J B, Schmidt, J, Huber, J, Spona
openaire   +2 more sources

Anaphylaxis From Medroxyprogesterone Acetate

Obstetrics & Gynecology, 2004
More than 30 million women in more than 90 countries use depot medroxyprogesterone acetate as an injectable contraceptive agent, and it is thought to be very safe. However, it should be recognized that serious and potentially life-threatening adverse effects can occur.A 40-year-old para 2 went into anaphylactic shock after receiving 150 mg of depot ...
Daniel O, Selo-Ojeme, Amna, Tillisi, Christopher C, Welch   +2 more
openaire   +2 more sources

A radioimmunoassay for serum medroxyprogesterone acetate

Journal of Steroid Biochemistry, 1978
Abstract A radioimmunoassay for measuring medroxyprogesterone acetate in serum or plasma is described using an antiserum produced against the steroid-3-carboxymethyloxime coupled to bovine serum albumin. The method has adequate accuracy, precision and sensitivity and the reliability criteria of the method are compared with those of other ...
K, Shrimanker, B N, Saxena, K, Fotherby
openaire   +2 more sources